Suppression of allograft rejection with anti-αβ T cell receptor antibody in rat corneal transplantation

Transplantation

Volumn 67, Issue 4, 1999, Pages 600-604

  Yamagami, Satoru ^a,b   Tsuru, Tadahiko ^a   Ohkawa, Taeko ^a   Endo, Hitoshi ^a   Isobe, Mitsuaki ^c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY R73; RNA; T LYMPHOCYTE RECEPTOR;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPH NODE; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL;

EID: 0033608389     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199902270-00019     Document Type: Article

References (36)

1. Price FW, Whitson WE, Marks RG. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology 1991; 98: 322.
2. Williams KA, Roder D, Esterman A, Muehlberg SM, Coster DJ. Factors predictive of corneal graft survival. Ophthalmology 1992; 99: 403.
3. Yamagami S, Suzuki Y, Tsuru T. Risk factors for graft failure in penetrating keratoplasty. Acta Ophthalmol Scand 1996; 74: 584.
4. He YG, Mellon J, Apte R, Niederkorn JY. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival. Invest Ophthalmol Vis Sci 1994; 35: 3218.
5. Yamagami S, Obata H, Tsuru T, Isobe M. Suppression of corneal allograft rejection after penetrating keratoplasty by antibodies to ICAM-1 and LFA-1 in mice. Transplant Proc 1995; 27: 1899.
6. Yamagami S, Tsuru T, Isobe M, Obata H, Suzuki J. The role of cell adhesion molecules in allograft rejection after penetrating keratoplasty in mice: clinical and immunohistochemical study. Graefe's Arch Clin Exp Ophthalmol 1996; 234: 382.
7. Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Exp Eye Res 1997; 65: 89.
8. Yamagami S, Isobe M, Yamagami H, Hori J, Tsuru T. Mechanism of concordant corneal xenograft rejection in mice: synergic effects of anti-leukocyte function associated antigen-1 monoclonal antibody and FK506. Transplantation 1997; 64: 42.
9. Kagaya F, Hori J, Yamagami S, et al. Immunosuppression of corneal allograft by anti-B7-1, anti-B7-2 antibodies in mice. Invest Ophthalmol Vis Sci 1997; 38: s421.
10. He Y, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 1991; 32: 2723.
11. Ayliffe W, Bell EB, McLeod D, Hutchinson IV. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol 1992; 76: 602.
12. Pleyer U, Milani JK, Dukes A, et al. Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. Invest Ophthalmol Vis Sci 1995; 36: 52.
13. Nishi M, Herbort CP, Matsubara M, et al. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. Invest Ophthalmol Vis Sci 1993; 34: 2477.
14. Minamoto A, Sakata H, Okada K, Fujihara M. Suppression of corneal graft rejection by subconjunctival injection of FK506 in a rat model of penetrating keratoplasty. Jpn J Ophthalmol 1995; 39: 12.
15. Hikita N, Lopez JS, Chan CC, Mochizuki M, Nussenblatt RB, de Smet MD. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci 1997; 38: 901.
16. Matsumoto Y, Tsuchida M, Hanawa H, Abo T. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor αβ antibody. Immunology 1994; 81: 1.
17. Yoshino S, Schlipkoter E, Kinne R, Hunig T, Emmrich F. Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the α/β T cell receptor. Eur J Immunol 1990; 20: 2805.
18. Kiely PDW, Thiru S, Oliveira DBG. Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab Invest 1995; 73: 284.
19. Knight RJ, Kurrle R, Stepkowski S, Serino F, Chou TC, Kahan BD. Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat α/β-T cell receptor monoclonal antibody. Transplantation 1994; 57: 1544.
20. Tsuchida M, Hirahara H, Matsumoto Y, Abo T, Eguchi S. Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor αβ antibody. Transplantation 1994; 57: 256.
21. Hofmann WJ, Terness CD, Thies J, et al. Lack of preferential Th1/Th2 cytokine gene expression patterns in both α/β T-cell tolerance and rejecting rat cardiac allografts. Transplant Proc 1995; 27: 232.
22. Heidecke CD, Hancock WW, Westerholt S, et al. α/β-T cell receptor-directed therapy in rat allograft recipients. Transplantation 1996; 61: 948.
23. Schorlemmer HU, Dickneite G, Kurrle R, Seiler FR. Synergistic effects of 15-deoxyspergualin with cyclosporine and the TCR-targeted monoclonal antibody R73 to induce specific unresponsiveness to skin allograft in rats. Transplant Proc 1995; 27: 414.
24. Wang M, Qu X, Strepkowski SM, Chou TC, Kahan BD. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus. Transplantation 1996; 61: 458.
25. Heidecke CD, Zantl N, Maier S, et al. Induction of long-term rat renal allograft survival by pretransplant T cell receptor-α/β-targeted therapy. Transplantation 1996; 61: 336.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
27. Sato Y, Ito K, Moritoyo T, et al. Human T-cell lymphotropic virus type 1 can infect primary rat retinal glial cells and induce gene expression of inflammatory cytokines. Curr Eye Res 1997; 16: 782.
28. Takeuchi M, Kosiewicz MM, Alard P, Streilein JW. On the mechanisms by which transforming growth factor-β2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol 1997; 27: 1648.
29. Sonoda Y, Streilein JY. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992; 54: 694.
30. Sonoda Y, Sano Y, Ksander B, Streilein JW. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 1995; 36: 427.
31. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci 1995; 36: 1530.
32. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching of donors and recipients in high risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392.
33. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18: 263.
34. Yamagami S, Kawashima H, Endo H, et al. Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation. Transplantation 1998; 66: 1504.
35. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplantation. Transplantation 1997; 64: 1107.
36. Mosmann DA, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 46: 111.